跳至主要内容
临床试验/CTRI/2013/11/004172
CTRI/2013/11/004172已完成3 期

Evaluation of Memantine for migraine prophylaxis

SRM University0 个研究点目标入组 60 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patients with of migraine as assessed by International Headache Society (IHS) criteria, for at least 6 months before screening
  • patients with between 3 and 12 migraines but no more than 15 headache days
  • Patients willing to give consent

排除标准

  • Patients having headaches other than migraine, episodic tension, or sinus headaches.
  • If headaches failed to respond to more than 2 adequate previous regimens of migraine preventive medications
  • Medication overuse headache
  • Pregnant/breast feeding women
  • Severe medical illness
  • renal insufficiency
  • Hypersensitivity

研究者

相似试验